'Braf' presentation slideshows

Sezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti

502 views • 49 slides

Recent progress of targeted kinase inhibitors in thyroid cancer

Recent progress of targeted kinase inhibitors in thyroid cancer. A/Prof Rory Clifton-Bligh Kolling Institute of Medical Research, University of Sydney Department of Endocrinology Royal North Shore Hospital, St Leonards, NSW. Royal North Shore Hospital.

646 views • 42 slides

Evolving Treatment Options in Melanoma: Utilizing Genetic Features to Optimize Therapy

In association with Translational Research in Oncology. Evolving Treatment Options in Melanoma: Utilizing Genetic Features to Optimize Therapy. Antoni Ribas, MD Professor Department of Medicine and Hematology-Oncology University of California, Los Angeles Los Angeles, California.

400 views • 31 slides

Maria Chiara Zatelli

290 views • 28 slides

t 2 group Introduction to the Welsh Language

393 views • 25 slides

392 views • 23 slides

GEFITINIB IN ESOPHAGEAL CANCER: JUST THE BEGINNING OF A SPICY STORY

GEFITINIB IN ESOPHAGEAL CANCER: JUST THE BEGINNING OF A SPICY STORY. A. D. Roth MD CC Oncosurgery HUG Geneva. Overall Survival. Boring! Another negative study in esophageal cancer!. Recrutement completed in 31 months, Congratulations!.

409 views • 22 slides

DEFINING THE ROLE OF MUTATED Hbraf IN MELANOGENESIS

DEFINING THE ROLE OF MUTATED Hbraf IN MELANOGENESIS. EUNICE ASARE Dr. ALAN HOUGHTON LABORATORY Memorial Sloan Kettering Cancer Center (MSKCC). INTRODUCTION. Melanoma is the deadliest skin cancer. It begins in melanocytes (cells responsible for skin pigmentation).

180 views • 17 slides

Detection of BRAF Mutations in Tumour and Serum of Patients with Advanced Melanoma

298 views • 14 slides

Emerging Concepts in the Diagnosis and Work-up of Thyroid Cancer

Emerging Concepts in the Diagnosis and Work-up of Thyroid Cancer. Short Presentation in Emerging Concepts (SPEC). Thyroid Nodules. Found in 4-7% of U.S. adults Approximately 5% are malignant. Fine needle aspiration (FNA) mainstay of diagnosis Bethesda system: Six diagnostic categories

279 views • 14 slides

DEVELOPMENTS IN TURKEY 2011-2012 DR. HAMIT ERSOY SECRETARY GENERAL OF BRAF, RTUK Member

DEVELOPMENTS IN TURKEY 2011-2012 DR. HAMIT ERSOY SECRETARY GENERAL OF BRAF, RTUK Member TIRANA, ALBANIA 25-26 May 2011. RTUK Annual Progress Report 2011-2012 . Developments in Turkey Landscape National Legislation Main Novelties introduced by the New Law

144 views • 14 slides

Perugia: Etruscan Arch

Perugia: Etruscan Arch. Perugia: Town Hall and Fountain. Perugia: University Medical Center. Visit of Dr. James Smith and his wife to our medical center. HAIRY CELL LEUKEMIA AS A PARADIGM FOR DEVELOPMENT OF NEW THERAPIES. Mutated BRAF (targeted therapy ?). Pentostatin Cladribin.

308 views • 13 slides

Emerging Concepts in the Diagnosis and Work-up of Thyroid Cancer

Emerging Concepts in the Diagnosis and Work-up of Thyroid Cancer. Short Presentation in Emerging Concepts (SPEC). Thyroid Nodules. Found in 4-7% of U.S. adults Approximately 5% are malignant. Fine needle aspiration (FNA) mainstay of diagnosis Bethesda system: Six diagnostic categories

339 views • 13 slides

???????????????? BRAF V600E ??

???????????????? BRAF V600E ??. ??????????? ?? 2014 ? 3 ? 26 ?. Homogeneity and heterogeneity. Detection comparison. Three technical problems. ????.

531 views • 9 slides

vector BRaf wt V599E D593V G463R G565R G465E

A B C. BRaf. vector BRaf wt V599E D593V G463R G565R G465E. cell lysates. pospho-Erk. BRaf. vector Braf wt V599E D593V G463R G465R G465E. kinase assay. pospho-Erk.

113 views • 1 slides

vector BRaf wt V599E V599R V599K

A B C. vector BRaf wt V599E V599R V599K. BRaf. Pospho-Erk.

147 views • 1 slides